Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.

The next new electric car from China to launch in Australia could be this ...

“The problem is that vitamin B6 is in a range of products, so it is easy to accidentally take too much without realizing,” ...

A fleet of Rivian EV pickups is heading to auction in Australia, though new owners might never get to drive them on public ...

ASX life science plays are increasingly turning to offshore deals and collaborations, notably in the difficult but promising ...

Astute Analytica released an extensive market assessment report titled “Global Shingles vaccine market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033.” This report offers a deep ...

Shah Capital frustrated with Novavax's weak COVID-19 vaccine sales Hedge fund increases stake to 8.3%, urges sale to large pharma Novavax's COVID vaccine sales lag behind competitors Nov 13 (Reuters) ...

Novavax, Inc. receives a Hold rating, reflecting improved prospects after its Sanofi partnership and upgraded 2025 revenue guidance to $1–1.05 billion. The SNY deal provides upfront payments, ...

Investors in Novavax, Inc. (Symbol: NVAX) saw new options become available today, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX ...

The Food and Drug Administration has approved Novavax's Nuvaxovid 2025-2026 formula for the prevention of COVID-19 in adults 65 years and older or individuals 12 years through 64 years of age with at ...